|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-2-14
|
|
pubmed:abstractText |
We investigated the clinical significance of excision repair cross-complementation group 1 (ERCC1), breast cancer susceptibility 1 (BRCA1), and class III ?-tubulin (TUBB3) expression in thymic epithelial tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ERCC1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Endonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/beta III-tubulin protein, human
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:AbeMasatoM,
pubmed-author:EndoMasahiroM,
pubmed-author:KairaKyoichiK,
pubmed-author:KairaRiekoR,
pubmed-author:KohYasuhiroY,
pubmed-author:KondoHaruhikoH,
pubmed-author:MiuraSatoruS,
pubmed-author:MurakamiHaruyasuH,
pubmed-author:NaitoTateakiT,
pubmed-author:NakagawaKazuoK,
pubmed-author:NakajimaTakashiT,
pubmed-author:OhdeYasuhisaY,
pubmed-author:OkumuraTakehiroT,
pubmed-author:SerizawaMasakuniM,
pubmed-author:TakahashiToshiakiT,
pubmed-author:YamamotoNobuyukiN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
606-13
|
|
pubmed:meshHeading |
pubmed-meshheading:21289518-Adult,
pubmed-meshheading:21289518-Aged,
pubmed-meshheading:21289518-Aged, 80 and over,
pubmed-meshheading:21289518-BRCA1 Protein,
pubmed-meshheading:21289518-DNA-Binding Proteins,
pubmed-meshheading:21289518-Endonucleases,
pubmed-meshheading:21289518-Female,
pubmed-meshheading:21289518-Humans,
pubmed-meshheading:21289518-Immunoenzyme Techniques,
pubmed-meshheading:21289518-Male,
pubmed-meshheading:21289518-Middle Aged,
pubmed-meshheading:21289518-Neoplasm Staging,
pubmed-meshheading:21289518-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:21289518-Organoplatinum Compounds,
pubmed-meshheading:21289518-Survival Rate,
pubmed-meshheading:21289518-Thymus Neoplasms,
pubmed-meshheading:21289518-Treatment Outcome,
pubmed-meshheading:21289518-Tubulin,
pubmed-meshheading:21289518-Tumor Suppressor Protein p53
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and ? III-tubulin in thymic epithelial tumors.
|
|
pubmed:affiliation |
Division of Thoracic Oncology, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan. kkaira1970@yahoo.co.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
